Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EFdA-TP, a highly potent nucleoside reverse transcriptase (RT) inhibitor, exerts its inhibitory effect on RT-catalyzed DNA synthesis through both immediate and delayed chain termination mechanisms, commonly referred to as ICT and DCT, respectively. Additionally, EFdA-TP demonstrates its efficacy in inhibiting HIV-1 RT through multiple pathways.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | EFdA-TP, a highly potent nucleoside reverse transcriptase (RT) inhibitor, exerts its inhibitory effect on RT-catalyzed DNA synthesis through both immediate and delayed chain termination mechanisms, commonly referred to as ICT and DCT, respectively. Additionally, EFdA-TP demonstrates its efficacy in inhibiting HIV-1 RT through multiple pathways. |
In vitro | EFdA-TP, in concentrations ranging from 0.05 to 10 μM for a duration of 15 minutes, acts as an immediate chain terminator (ICT) or delayed chain terminator (DCT) to inhibit reverse transcriptase (RT)-catalyzed DNA synthesis [1]. As a translocation-defective RT inhibitor, it significantly decelerates DNA synthesis, effectively acting as an immediate chain terminator, while also possessing the capability to function as a delayed chain terminator by permitting the addition of one more deoxynucleotide triphosphate (dNTP) prior to halting DNA synthesis [1]. |
Molecular Weight | 533.195 |
Formula | C12H15FN5O12P3 |
CAS No. | 950913-56-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EFdA-TP 950913-56-1 EFdA TP EFdATP inhibitor inhibit